Eplerite 25 Tablet contains Eplerenone 25 mg, a selective aldosterone receptor antagonist indicated primarily for the management of hypertension and heart failure post-myocardial infarction. By competitively blocking aldosterone receptors in the distal renal tubules, Eplerenone promotes sodium and water excretion while conserving potassium, thereby reducing blood volume and systemic vascular resistance. This mechanism contributes to improved cardiac remodeling and decreased morbidity and mortality in patients with left ventricular dysfunction following myocardial infarction. Eplerite 25 is typically administered once daily, with dosage adjustments based on clinical response and renal function. It is contraindicated in patients with hyperkalemia, significant renal impairment, or hypersensitivity to the drug. Common adverse effects include hyperkalemia, dizziness, and gastrointestinal disturbances. Regular monitoring of serum potassium and renal function is essential during therapy to minimize the risk of adverse events. Eplerite 25 should be used cautiously in patients receiving other potassium-sparing agents or potassium supplements. Its role in cardiovascular therapy underscores its importance in comprehensive management strategies aimed at reducing the progression of heart failure and controlling elevated blood pressure, thereby improving patient outcomes.

Dosage & How to Use